The studies above identify common characteristics of resistant phenotypes in melanoma and other cancers, which include dedifferentiation, mitogenic rewiring, chromatin restructuring and inflammatory signalling especially via IFN pathway enrichment. This evidence concerns the gene IFNA1 and cancer.